543434 Stock Overview
Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 4/6 |
Past Performance | 4/6 |
Financial Health | 6/6 |
Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for 543434 from our risk checks.
Supriya Lifescience Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹410.15 |
52 Week High | ₹423.50 |
52 Week Low | ₹214.45 |
Beta | 0.25 |
1 Month Change | 8.08% |
3 Month Change | 38.63% |
1 Year Change | 85.80% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 5.07% |
Recent News & Updates
Recent updates
Shareholder Returns
543434 | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | -0.1% | 0.9% | 1.0% |
1Y | 85.8% | 57.7% | 44.8% |
Return vs Industry: 543434 exceeded the Indian Pharmaceuticals industry which returned 57.7% over the past year.
Return vs Market: 543434 exceeded the Indian Market which returned 44.8% over the past year.
Price Volatility
543434 volatility | |
---|---|
543434 Average Weekly Movement | 7.7% |
Pharmaceuticals Industry Average Movement | 6.0% |
Market Average Movement | 6.7% |
10% most volatile stocks in IN Market | 10.0% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 543434's share price has been volatile over the past 3 months.
Volatility Over Time: 543434's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1987 | 392 | Rajeev Jain | www.supriyalifescience.com |
Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. It offers anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, and anti-malarial products, as well as vitamins and xanthine derivatives. The company was founded in 1987 and is headquartered in Mumbai, India.
Supriya Lifescience Limited Fundamentals Summary
543434 fundamental statistics | |
---|---|
Market cap | ₹33.69b |
Earnings (TTM) | ₹1.20b |
Revenue (TTM) | ₹5.54b |
27.4x
P/E Ratio6.0x
P/S RatioIs 543434 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
543434 income statement (TTM) | |
---|---|
Revenue | ₹5.54b |
Cost of Revenue | ₹2.26b |
Gross Profit | ₹3.28b |
Other Expenses | ₹2.08b |
Earnings | ₹1.20b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 14.96 |
Gross Margin | 59.18% |
Net Profit Margin | 21.72% |
Debt/Equity Ratio | 0.8% |
How did 543434 perform over the long term?
See historical performance and comparison